NHS England

Public body — contracts awarded

£50.2bnTotal value£50,213,880,549 across every award on file
1269Awardspublished since 4 July 2024

Who they buy from

Every award on file

AwardedWhat forBuyerSupplierValue
4 Mar 2026 New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland NHS England Willmott Dixon Construction Limited +9 £37.0bn
24 Mar 2025 NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands NHS England CSL Behring UK Ltd +71 £1.2bn
1 Jul 2025 NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 NHS England Biogen +20 £986.3m
19 Dec 2024 NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland NHS England CSL Behring UK Ltd +5 £905.2m
31 May 2024 NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands NHS England Pfizer Ltd +8 £765.0m
28 Oct 2024 NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 NHS England Gilead Sciences Limited +12 £626.5m
16 Jun 2025 NHS National Pharmaceuticals Generic Products Wave 15bEast Midlands NHS England £459.7m
21 Mar 2025 Cloud Service Delivery Partner (CSDP)England NHS England SOFTCAT PLC £440.0m
21 Mar 2025 Cloud Service Delivery Partner (CSDP)England NHS England SOFTCAT PLC £440.0m
25 Jul 2024 NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 NHS England Bayer Plc +8 £416.8m
22 Jul 2024 NHS Branded Medicines Tranche Framework for London and South of EnglandEast Midlands NHS England Sun Pharma UK Ltd +28 £381.0m
4 Mar 2025 New Hospital Programme - Programme Delivery Partner (PDP)England NHS England MACE CONSULT LIMITED £307.0m
4 Mar 2025 New Hospital Programme - Programme Delivery Partner (PDP)England NHS England MACE CONSULT LIMITED £307.0m
4 Mar 2025 New Hospital Programme - Programme Delivery Partner (PDP)England NHS England MACE CONSULT LIMITED £307.0m
25 Jun 2025 NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National NHS England Roche Products Ltd +27 £261.9m
13 Aug 2024 CM/TNS/24/5711 -NHS Framework for the supply of UstekinumabEast Midlands NHS England Amgen Ltd +5 £230.0m
16 Aug 2024 NHSmail Collaboration Licensing PlatformEngland NHS England ACCENTURE (UK) LIMITED £223.0m
16 Aug 2024 NHSmail Collaboration Licensing PlatformEngland NHS England ACCENTURE (UK) LIMITED £223.0m
31 Jan 2026 NHS England Bowel Cancer Screening Programme Managed ServiceEngland NHS England GXO LOGISTICS UK LIMITED £210.5m
31 Jan 2026 NHS England Bowel Cancer Screening Programme Managed ServiceEngland NHS England GXO LOGISTICS UK LIMITED £210.5m
27 Mar 2026 NHS App NHS England IBM UNITED KINGDOM LIMITED £160.1m
27 Mar 2026 NHS App NHS England IBM UNITED KINGDOM LIMITED £160.1m
27 Mar 2026 NHS App NHS England IBM UNITED KINGDOM LIMITED £160.1m
29 Jan 2025 Appointments & Patient ChoiceEngland NHS England ACCENTURE (UK) LIMITED £124.1m
29 Jan 2025 Appointments & Patient ChoiceEngland NHS England ACCENTURE (UK) LIMITED £124.1m

Organisations are grouped by name, because the notices carry no identifier that appears on all of them. A body that publishes under two spellings will appear twice; two different companies with the same trading name will appear as one. Check the individual notices before drawing a conclusion.